Abstract:Background: Noonan syndrome (NS) is a clinically and genetically heterogeneous disorder. Since its clinical phenotype is often mild and difficult to differentiate from other syndromes, its diagnosis can be challenging and its prevalence in the pediatric population is most certainly underestimated. The difficulty in identifying Noonan syndrome is also increased by the fact that genetic tests are currently not able to detect an underlying mutation in around 10% of the cases. Methods: This is a retrospective, observational study conducted at the Institute for Maternal and Child "Burlo Garofolo" in Trieste, Italy. We recruited all the patients with clinical and/or genetic diagnosis of NS who were evaluated at the Department of Pediatrics between October 2015 and October 2020. Statistical analyses were performed with IBM SPSS Statistics software. The association between discrete variables has been evaluated through chi-squared test, indicating statistically significant p with Pearson test or Fischer test for variables less than 5. Results: We recruited a total of 35 patients affected by Noonan syndrome. In 24 patients (75%) we identified an underlying genetic substrate: 17 patients had a mutation on PTPN11 (61%), 2 in SOS1, KRAS and SHOC2 (7% each) and only 1 in RAF1 (4%). 25% of the subjects did not receive a genetic confirm. As for the phenotype of the syndrome, our study identified the presence of some clinical features which were previously unrelated or poorly related to NS. For example, renal and central nervous system abnormalities were found at a higher rate compared to the current literature. On the contrary, some features that are considered very suggestive of NS (such as lymphatic abnormalities and the classical facial features) were not frequently found in our population. Conclusions: In our analysis, we focused on the main phenotypic features of NS, identifying various clinical manifestation that were not associated with this genetic condition before. This could be helpful in raising the knowledge of NS's clinical spectrum, facilitating its diagnosis.

Further case of enlarged spinal nerve roots in KRAS-related Noonan syndrome

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

New Insights Into the Spectrum of RASopathies: Clinical and Genetic Data in a Cohort of 121 Spanish Patients

Mosaic segmental orofacial overgrowth with hyperplastic nerves and neurofibromas characterized by KRAS G12dup pathogenic variant

[New Insight of Craniofacial and Oral Findings of the RASopathies].

Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome

Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome

Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders

Functional analysis of RRAS2 pathogenic variants with a Noonan-like phenotype

New insights on Noonan syndrome's clinical phenotype: a single center retrospective study

Molecular And Phenotypic Spectrum Of Noonan Syndrome In Chinese Patients

RASopathies influences on neuroanatomical variation in children.

Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies

Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examined

New insights into the molecular basis of spinal neurofibromatosis type 1

Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome

Noonan syndrome and type 1 Chiari malformation: Possible association

Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis

Cardiac Phenotype and Gene Mutations in RASopathies

Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features

Recurrent cellulitis and bacteremia in a patient with Noonan syndrome: A case report